Recent

% | $
Quotes you view appear here for quick access.

công ty Albany Molecular Research Message Board

  • pianomag101 pianomag101 Sep 1, 2005 5:55 PM Flag

    AMRI UNDER HEAVY ACCUMULATION

    contantly testing the lows of 16, constantly going more and more up. Looks like we're headed to 20.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Down $1.43 in pre-market - I didn't know heavy accumulations caused a price drop. I am a little confused therefore on how 20 will be reached?

      Will this news help:

      Teva, Barr to launch generic Allegra
      Tuesday September 6, 8:31 am ET


      CHICAGO (Reuters) - Barr Pharmaceuticals Inc. (NYSE:BRL - News) and Teva Pharmaceutical Industries (NasdaqNM:TEVA - News; Tel Aviv:TEVA.TA - News) on Tuesday said they have entered into an agreement to launch a generic version of Sanofi-Aventis' (Paris:SASY.PA - News) Allegra allergy tablets.

      Barr last week received U.S. regulatory approval to sell the copycat drug. At the time, Barr said it believed it was the first company to seek U.S. approval for generic Allegra, which would give it 180 days of marketing exclusivity.

      For Teva, which has been pursuing its own generic version of Allegra, the deal with Barr allows it to launch earlier.

 
AMRI
19.87+0.12(+0.61%)1:44 PMEDT